SCHEMBL9488796

SCHEMBL9488796

CCCOc1ccc([C@@]2(Cn3ccnc3)OC[C@@H](CSc3ccc(NC(=O)OCC)cc3)O2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 5/20 0.43
CYP3A4 P08684 9/20 0.41
CYP19A1 P11511 6/20 0.41
CYP17A1 P05093 5/20 0.41
CYP21A2 P08686 4/20 0.41
CYP11B1 P15538 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
USP2 O75604 2/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP51A1 Q16850 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
SLC22A1 O15245 1/20 0.41
ABCC4 O15439 1/20 0.41
CYP27B1 O15528 1/20 0.41
CYP26A1 O43174 1/20 0.41
NR1I2 O75469 1/20 0.41
GMNN O75496 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9488791 1.00 TBXAS1 (0.43) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
Erbulozole SCHEMBL9488172 0.92 CYP3A4 (0.40) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
Erbulozole SCHEMBL9488166 0.92 CYP3A4 (0.40) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
Erbulozole SCHEMBL3824 0.92 CYP3A4 (0.40) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
Erbulozole SCHEMBL27849451 0.91 CYP3A4 (0.40) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
SCHEMBL9490323 0.90 CYP3A4 (0.39) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
SCHEMBL10515317 0.89 CYP3A4 (0.43) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
SCHEMBL9488205 0.84 CYP3A4 (0.42) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
SCHEMBL9488211 0.84 CYP3A4 (0.42) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2
SCHEMBL9489826 0.84 CYP3A4 (0.42) TBXAS1CYP3A4CYP19A1CYP17A1CYP21A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236944-A C1-4 alkyl(4-(2-(4-C1-4-alkylphenyl)-2(1H-imidazol-1-ylmethyl) -1,3-dioxolan-4-ylemthlthio)phenyl)carbamate JANSSEN PHARMACEUTICA N.V. (BE) 1993-08-17 US disclosed